These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7131953)

  • 21. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of N,N'-diallylpentobarbital potentiation of pentobarbital-induced sleep in mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):173-85. PubMed ID: 3659568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administration.
    Muhoberac BB; Hanew T; Halter S; Schenker S
    Biochem Pharmacol; 1989 Nov; 38(22):4103-13. PubMed ID: 2512932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic aminopyrine N-demethylase system: further studies of assay procedure.
    Matsubara T; Touchi A; Tochino Y
    Jpn J Pharmacol; 1977 Feb; 27(1):127-36. PubMed ID: 559190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression of hepatic microsomal enzyme systems by lentinan in mice.
    Sasaki K; Sasaki M; Ishikawa M; Takayanagi G
    Jpn J Pharmacol; 1985 Jan; 37(1):107-15. PubMed ID: 3990039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states.
    Wade AE; Evans JS
    Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the metabolism of hexobarbital and aminopyrine in vivo in rats.
    van der Graaff M; Vermeulen NP; Heij P; de Bree H; Breimer DD
    Xenobiotica; 1986 Dec; 16(12):1091-6. PubMed ID: 3798956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
    Kato Y; Kimura R
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on drug metabolizing activity in rat liver microsomes.
    Okuno H; Murase T; Nakanishi S; Shiozaki Y; Sameshima Y
    Jpn J Pharmacol; 1987 Jul; 44(3):303-10. PubMed ID: 3116305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial inhibition of hepatic microsomal aminopyrine N-demethylase by caffeine in partially purified cytochrome P450.
    Govindwar SP; Kachole MS; Pawar SS
    Biochim Biophys Acta; 1983 Mar; 756(2):191-5. PubMed ID: 6830852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the oxidative metabolism of drugs by liver microsomes.
    Kato R; Takayanagi M; Oshima T
    Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of anti-basic liver protein antibody-induced liver injury on hepatic drug-metabolizing enzymes in C57 BL/6J mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 1993 Oct; 16(10):982-8. PubMed ID: 8287050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A protein inhibitor of hepatic drug metabolizing enzymes from Ehrlich ascites cells.
    Kamat JP
    Cancer Lett; 1997 Feb; 113(1-2):1-8. PubMed ID: 9065794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on age difference in mice for the activity of drug-metabolizing enzymes of liver microsomes.
    Kato R; Takanaka A; Onoda K
    Jpn J Pharmacol; 1970 Dec; 20(4):572-6. PubMed ID: 5312939
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic toxicity of cimetidine on hepatic and renal drug metabolism.
    Solangi KB; Lutton JD; Svogun JA; Ibraham NG; Goodman AI; Levere RD
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):19-35. PubMed ID: 6548043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of methylbenzenes on microsomal enzymes in rat liver, kidney and lung.
    Pyykkö K
    Biochim Biophys Acta; 1980 Nov; 633(1):1-9. PubMed ID: 6778508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract]   [Full Text] [Related]  

  • 40. Presence of hexobarbital in primary cultures of rat hepatocytes maintains cytochrome P-450 levels and drug metabolizing enzyme activities.
    Kim HM; Ha JR; Park SK; Yang KH
    Drug Chem Toxicol; 1988; 11(1):29-41. PubMed ID: 3259924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.